These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 5172576)
1. [Effect of reserpine on blood lipid and urine catecholamine levels in patients with diffuse toxic goiter]. Baranov VG; Zaripova ZKh; Slobodskoĭ VR; Ugoleva SV Ter Arkh; 1971 Jul; 43(7):98-102. PubMed ID: 5172576 [No Abstract] [Full Text] [Related]
2. [Mechanism of the antithyroid effect of reserpine in patients with diffuse toxic goiter]. Komarovskaia RP; Potin VV; Ugoleva SV Probl Endokrinol (Mosk); 1970; 16(4):9-14. PubMed ID: 4102831 [No Abstract] [Full Text] [Related]
3. [Urinary excretion of catecholamines in patients with Graves-Basedow disease and hyperactive nodular goiter before and after treatment with propranolol]. Mieczkowska J Ann Univ Mariae Curie Sklodowska Med; 1983; 38():307-14. PubMed ID: 6600077 [No Abstract] [Full Text] [Related]
4. [Dynamics of serum lipid changes in patients with diffuse toxic goiter during treatment with I-131]. Slukhaĭ IuF Med Radiol (Mosk); 1967 May; 12(5):67-9. PubMed ID: 5633311 [No Abstract] [Full Text] [Related]
5. [The level of lecithin, cholesterol and its fractions in the blood in diffuse toxic goiter]. Slukhaĭ IuF Sov Med; 1967 Oct; 30(10):45-9. PubMed ID: 5632742 [No Abstract] [Full Text] [Related]
6. Another polyendocrine disorder: pheochromocytoma and diffuse toxic goiter. Braverman LE; Sullivan RM Johns Hopkins Med J; 1969 Dec; 125(6):331-5. PubMed ID: 4190005 [No Abstract] [Full Text] [Related]
8. [Effect of glucocorticosteroids on the immunological indices of diffuse toxic goiter patients]. Epishin AV Vrach Delo; 1984 Jul; (7):41-3. PubMed ID: 6332424 [No Abstract] [Full Text] [Related]
9. [Excretion of catecholamines in the dynamics of the therapy of diffuse toxic goiter]. Ugoleva SV Ter Arkh; 1967 Feb; 39(2):43-8. PubMed ID: 5632980 [No Abstract] [Full Text] [Related]
10. [Use of zymosan and levamisole in the complex treatment of patients with diffuse toxic goiter]. Epishin AV; Epishina NA Ter Arkh; 1986; 58(10):108-12. PubMed ID: 3798334 [No Abstract] [Full Text] [Related]
12. [Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment]. Epishin AV Klin Med (Mosk); 1984 Aug; 62(8):90-3. PubMed ID: 6333549 [No Abstract] [Full Text] [Related]
13. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism]. Bürgi U; Gerber H; Peter HJ Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825 [TBL] [Abstract][Full Text] [Related]
14. [Clinical effect and dynamics of immunologic indices in patients with acute toxic goiter during treatment with glucocorticoids]. Epishin AV; Epishina NA Klin Med (Mosk); 1986 May; 64(5):96-100. PubMed ID: 3755191 [No Abstract] [Full Text] [Related]
15. Estimation of urinary catecholamines in cases of hypertension before and during hypotensive therapy. Sikka KK; Misra SS; Mital HS; Dalmia SS; Gupta KS Indian Heart J; 1968 Jul; 20(3):344-8. PubMed ID: 5705277 [No Abstract] [Full Text] [Related]
16. [Lithium carbonate in the treatment of diffuse toxic goiter]. Leshchinskiĭ LA; Trusov VV; Pimenov LT Ter Arkh; 1982; 54(2):113-8. PubMed ID: 6803379 [No Abstract] [Full Text] [Related]
17. [Diseases of the thyroid gland]. Med Klin; 1967 May; 62(20):796-8. PubMed ID: 5631330 [No Abstract] [Full Text] [Related]
18. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma]. Hansen PE Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284 [No Abstract] [Full Text] [Related]